欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Cancer

货号 产品名 CAS号 信息
CSN18928 COH29 1190932-38-7 COH29 is a potent ribonucleotide reductase (RNR) inhibitor with anticancer activity with IC50 value of 8 μM in KB cell.
CSN18942 KRIBB11 342639-96-7 KRIBB11 is an inhibitor of heat shock factor (HSF) inhibitor, with IC50 of 1.2 μM.
CSN18997 6,7-Dimethoxy-N-(2-methyl-4-phenoxyphenyl)quinazolin-4-amine hydrochloride 2002381-31-7 APS-2-79 HCl is a KSR (Kinase suppressor of Ras)-dependent MAPK modulator which can stabilize KSR inactive state with an IC50 value of 120 nM, resulting in inhibition of oncogenic Ras signaling, antagonizing the Ras–MAPK pathway.
CSN18952 BI-9564 1883429-22-8 BI-9564 is an inhibitor of BRD9 (IC50 = 75 nM) and BRD7 (IC50 = 3.4 µM).
CSN18941 Apoptozole 1054543-47-3 Apoptozole is an inhibitor of heat shock protein 70 (HSP70) and Hsc70. It induces caspase-dependent apoptosis.
CSN18947 SF1670 345630-40-2 SF1670 is a selective PTEN inhibitor with IC50 value of 2 μM.
CSN18937 N-(3-(((2-Hydroxynaphthalen-1-yl)methylene)amino)phenyl)-2-phenylpropanamide 1105698-15-4 Salermide, a reverse amide, can act as an inhibitor of sirt, especially of sirt2, with the property of inducing apoptosis of tumor cells.
CSN18940 Sirtuin modulator 1 2070015-26-6 SRT3025 HCl is an orally available sirtuin modulator.
CSN18956 MM-102 TFA 1883545-52-5 MM-102 trifluoroacetate is a potent WDR5/mLL interaction inhibitor, achieves IC50 = 2.4 nM with an estimated Ki < 1 nM in WDR5 binding assay, which is > 200 times more potent than the ARA peptide.
CSN18970 6H05 trifluoroacetate 2061344-88-3 6H05 trifluoroacetate is a selective, and allosteric inhibitor of oncogenic mutant K-Ras (G12C).
CSN18953 GSK6853 1910124-24-1 GSK6853 selectively inhibits the BRPF1 bromodomain with the pKd value of 9.5.
CSN18955 SGC2085 1821908-48-8 SGC2085 is a selectivel and potent CARM1 inhibitor with IC50 value of 50 nM.
CSN18935 Tirbanibulin Mesylate 1080645-95-9 KX2-391 mesylate is an inhibitor of Src that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.
CSN19011 Naquotinib mesylate 1448237-05-5 Naquotinib mesylate is a mutant-selective irreversible EGFR inhibitor with IC50 of 70 nM for NCI-H1650 cell growth,inhibits growth of non-small cell lung cancer (NSCLC) cells with EGFR activating and T790M resistance mutations.
CSN18950 E7820 289483-69-8 E7820 is an angiogenesis inhibitor by suppressing integrin a2, a cell adhesion molecule expressed on endothelial cells.
CSN18996 Motixafortide 664334-36-5 BKT140 is a CXCR4 antagonist with an IC50 value of ~1 nM.
CSN18933 Soblidotin 149606-27-9 Auristatin PE is a synthetic Dolastatin 10 derivative and inhibitor oftubulinpolymerization.
CSN18965 DDP-38003 2HCl 1831167-98-6 DDP-38003 2HCl is an orally available inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) with an IC50 of 84 nM.
CSN18944 Debio 0932 1061318-81-7 Debio 0932 is a heat shock protein 90 (HSP90) inhibitor with strong affinity for HSP90 alpha/beta, high oral bioavailability and potent anti-proliferative activity against a broad range of cancer cell lines (with a mean IC50 of 220 nmol/L).
CSN18974 CFMTI 864864-17-5 CFMTI is a potent and selective metabotropic glutamate receptor (mGluR)1 allosteric antagonist with IC50 of 2.6 nM.
CSN18986 Amiselimod HCl 942398-84-7 Amiselimod HCl is a sphingosine 1-phosphate receptor-1 (S1P1) modulator, designed to reduce the bradycardia effects associated with fingolimod and other S1P receptor modulators.
CSN18924 Ellipticine HCl 5081-48-1 Ellipticine HCl is a potent antineoplastic agent and inhibits DNA topoisomerase II activities.
CSN18964 EPZ031686 2095161-11-6 EPZ031686 is a noncompetitive inhibitor for SMYD3 and MEKK2 with a Ki=1.2 nM and 1.1 nM respectively.
CSN18987 ARS-853 1629268-00-3 ARS-853 is an inhibitor of KRAS G12C with IC50 of 2.5 μM.
CSN18967 Ilginatinib maleate 1354799-87-3 NS-018 maleate is an ATP-competitive small-molecule inhibitor of JAK2 with IC50 of 470?nM in Ba/F3-JAK2V617F cells .
CSN18925 CCT244747 1404095-34-6 CCT244747 is potent, highly selective, orally active, ATP competitive CHK1 inhibitor with IC50 of 29-170nM.
CSN18995 MK-0812 Succinate 851916-42-2 MK-0812 succinate is a potent and selective CCR2 antagonist with low nM affinity for CCR2 on human monocytes.
CSN18976 DFMTI 864864-86-8 DFMTI can completely block the rmGlu1 L757V glutamate response.
CSN18966 NVP-BSK805 2HCl 1942919-79-0 NVP-BSK805 2HCl is a potent and selective ATP-competitive JAK2 inhibitor with IC50 of 0.5 nM and > 20-fold selectivity towards JAK1, JAK3 and TYK2.
CSN18978 TCS-OX2-29 372523-75-6 TCS-OX2-29 is a potent and selective orexin 2 (OX2) receptor antagonist with IC50 of 40 nM.
CSN18934 PF-2771 2070009-55-9 PF-2771 is a potent, selective CENP-E inhibitor, PF-2771 inhibits CENP-E motor activity with an IC50 of 16.1 ± 1.2 nM.
CSN18926 NU6300 2070015-09-5 NU6300 is the first covalent ATP-competitive CDK2 inhibitor.
CSN18927 ML241 HCl 2070015-13-1 ML241 HCl is a potent and selective inhibitors of p97 ATPase with IC50 values of 100 nM.
CSN18921 Pyridostatin HCl 1781882-65-2 Pyridostatin HCl is a G-quadruplex-interacting drug which can promote growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage.
CSN18929 SJB3-019A 2070015-29-9 SJB3-019A is a potent USP1 inhibitor, 5 times more potent than SJB2-043 in promoting ID1 degradation and cytoxicity in K562 cells with IC50 of 0.0781 μM.
CSN18930 THZ1 Hydrochloride 2070018-35-6 THZ1 HCl is a selective and potent covalent CDK7 inhibitor with IC50 of 3.2 nM.
CSN18932 BAY1217389 1554458-53-5 BAY1217389 is a potent, and selective inhibitor of the monopolar spindle 1 (MPS1) kinase with an IC50 value less than 10 nM.
CSN18943 PU-H71 HCl 2095432-24-7 PU-H71 HCl is a potent Hsp90 inhibitor with IC50 of 50 nM.
CSN18954 MS049 1502816-23-0 MS 049 is a potent, selective, and cell-active dual inhibitor of PRMT4 and PRMT6 with IC 50 of 34 nM and 43 nM respectively.
CSN18963 CBB1003 hydrochloride 2070015-02-8 CBB1003 HCl is a histone demethylase LSD1 inhibitor with IC50 of 10.54 μM.
CSN18957 BET-BAY 002 (S enantiomer) 2070009-49-1 BET-BAY 002 S-enantiomer is the S-enantiomer of BET-BAY 002.
CSN18951 OSU-T315 2070015-22-2 ILK-IN-2 is a ILK inhibitor.
CSN18958 CARM1-IN-1 HCl 2070018-31-2 CARM1-IN-1 HCl is a potent and specific CARM1 (Coactivator-associated arginine methyltransferase 1) inhibitor with IC50 of 8.6 μM and shows very low activity against PRMT1 and SET7 (IC50 > 600 μM).
CSN18959 CBB1007 hydrochloride 2070014-96-7 CBB1007 HCl is a cell-permeable amidino-guanidinium compound that acts as a potent, reversible and substrate competitive LSD1 selective inhibitor (IC50 = 5.27 μM for hLSD1).
CSN18960 CBB1007 3HCl 2070015-03-9 CBB1007 3HCl is a cell-permeable amidino-guanidinium compound that acts as a potent, reversible and substrate competitive LSD1 selective inhibitor (IC50 = 5.27 μM for hLSD1).
CSN19008 (1S,3R,5R)-PIM447 dihydrochloride 2096989-57-8 (1S,3R,5R)-PIM447 2HCl an PIM inhibitor with IC50 values of 0.095 μM for Pim1, 0.522 μM for Pim2 and 0.369 μM for Pim3.
CSN19010 Naquotinib 1448232-80-1 Naquotinib is an irreversible mutant EGFR inhibitor with potential antineoplastic activity.
CSN18931 Monastrol 329689-23-8 Monastrol is a specific and allosteric inhibitor of mitotic molecular motor kinesin Eg5 with IC50 value of 14 μM.
<< PREV 8 9 10 11 12 13 14 15 16 NEXT >>
联系
我们